Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Monday, September 28

5:15 PM - 5:20 PM ET

1080 - Validation of an Automated Segmentation and Planning Reference Generation System for Gynecologic HDR Brachytherapy
Speaker: Marchant, Rebecca, MD - University of California at San Diego, La Jolla, CA
5:15 PM - 5:20 PM ET

1093 - Real-World Outcomes of Radiotherapy Alone in 1802 Patients with Stage II-III NSCLC
Speaker: van Diessen, Judi, MD, PhD - NKI-AvL, Amsterdam, Noord-Holl
5:15 PM - 5:20 PM ET

1099 - Implementing a Simulation-Free Workflow in Palliative Radiotherapy for Bone Metastases: Dosimetric Evaluation of Diagnostic CT-Based Planning Using 3D-CRT and VMAT
Speaker: Karaman, Emre, MD - Ege University Hospital, Izmir
5:15 PM - 5:20 PM ET

1105 - SFRT vs. CRT/SBRT: A Clinical Trials Simulated (CTS) Study on Short-Term Objective Response Rate, Long-Term Local Control Rate and Efficacy Gain Prediction for Bulky Tumors
Speaker: Bi, Suyan - Post-Doctoral Research Center, Yuebei People's Hospital, Southern Medical University, Shaoguan, Guangdong Province, China, Shaoguan
5:15 PM - 5:20 PM ET

1129 - Multicenter MRI-Only vs. CT planning for Prostate Cancer: Implementation, Dosimetry and One-Year Quality of Life Outcomes
Speaker: Young, Tony, MD, PhD - Institute of Medical Physics, School of Physics, University of Sydney,, Sydney
5:20 PM - 5:25 PM ET

1069 - SETD2 Loss Enhances Radiosensitivity and Predicts Improved Survival in High-Grade Gliomas
Speaker: Suh, Won Young - Department of Radiation Oncology, Seoul National University College of Medicine, Seoul
5:20 PM - 5:25 PM ET

1081 - Nab-Paclitaxel and Cisplatin with Image Guided Volumetric Modulated Arc Therapy for Locally Advanced Cervical Cancer: A Multicenter, Single-Arm Phase II Trial
Speaker: Wei, Shuhua, PhD - Peking University Third Hospital, Department of Radiation Oncology, Beijing
5:20 PM - 5:25 PM ET

1094 - Risk Classifier for Treatment of Stage III Non-Small Cell Lung Cancer Using Competing Event Regression: Ancillary Analysis of RTOG 0617
Speaker: Morse, Ryan, MD - University of Kansas Medical Center, Kansas City, KS
5:20 PM - 5:25 PM ET

1100 - Cost Effectiveness of Prophylactic Bone Irradiation for Prevention of Skeletal-Related Events in Patients with Metastatic Solid Cancers
Speaker: Chacko, Sarah - Geisel School of Medicine at Dartmouth, Lebanon, WA
5:20 PM - 5:25 PM ET

1106 - Toward a Common Biological Dose Scale for SBRT and SIRT Using Imaging-Derived Liver Functional Toxicity Response
Speaker: Wei, Lise, PhD, MS - University of Michigan, Ann Arbor, MI
5:20 PM - 5:25 PM ET

1130 - Differential Association of Post-Testosterone Recovery PSA Kinetics with Progression and Metastatic Outcomes In Prostate Cancer
Speaker: Roy, Soumyajit, MBBS, MSc. - University Hospitals Seidman Cancer Center, Cleveland, OH
5:20 PM - 5:30 PM ET

228 - Circulating Tumor DNA Positivity after Chemoradiation Marks an Imminent High-Risk State in Anal Squamous Cell Carcinoma
Speaker: Liu, Elisa, MD, BS - Memorial Sloan Kettering Cancer Center, New York, NY